Stock Alert: SELLAS Life (SLS) Climbing 16.74% in Pre-Market Move for June 23

Equities Staff  |

SELLAS Life Sciences Group Inc (NASDAQ:SLS) has already risen $0.39 in early trading Thursday.

After closing the previous trading session at $2.33, SELLAS Life has moved 16.74% higher ahead of market open.

The company has decreased 5.67% over the last 5 days.

Today could shape up to be an attractive day for SELLAS Life investors.

For technical charts, analysis, and more on SELLAS Life Sciences Group Inc visit the company profile.

Pre-market prices and movements as of 08:11:47 est.

About SELLAS Life Sciences Group Inc

SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapeutics for a broad range of cancer indications. SELLAS' lead product candidate, GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination to address a broad spectrum of hematologic malignancies and solid tumor indications. SELLAS' second product candidate, NPS, is a HER2-directed cancer immunotherapy with potential for the treatment of patients with early-stage breast cancer with low to intermediate HER2 expression, otherwise known as HER2 1+ or 2+, which includes triple negative breast cancer patients, following standard of care.

To get more information on SELLAS Life Sciences Group Inc and to follow the company's latest updates, you can visit the company's profile page here: SELLAS Life Sciences Group Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content